Genomic studies open up a wealth of bioactive small molecules in insect-killing bacteria

Genomic studies open up a wealth of bioactive small molecules in insect-killing bacteria
Life cycle of the entomopathogenic bacteria–nematode complex and the pangenomic approach used in this study: Bacteria of the genera Photorhabdus and Xenorhabdus live as symbionts in the intestines of soil-dwelling nematodes of the genera Heterorhabditis and Steinernema. The nematodes infect insect larvae in which they inject the bacteria. The bacteria in turn kill the insect larvae, which then become a food source for both bacteria and nematodes. Despite its complexity, this tripartite model system can be studied in the laboratory in various sub-combinations and at all life stages.   Credit: MPI f. Terrestrial Microbiology/ Shi

When bacteria interact with other organisms, a myriad of bacterial natural products are involved. In most cases, it is not possible to trace which bacterial strain produces which natural substance and what properties it has. And thus products such as colibactin from human intestinal bacteria involved in cancer development remain the exception rather than the rule.

Xenorhabdus and Photorhabdus live in symbiosis with specific nematodes. Jointly, they infect and kill soil-dwelling insect larvae. Within this relationship, the are responsible for the production of numerous toxins and other interaction-mediating substances. At the same time, they can be cultured and genetically manipulated in the laboratory in the absence of their nematode host. Therefore, they are considered promising research models for studying the chemical ecology of bacterial .

Now, for the first time, the bacteria have been systematically studied in a combination of pangenomic and domain sequence similarity analysis with respect to two central questions: which are responsible for natural product production, and are they evolutionarily conserved or unique to these bacterial genera?

Unknown biosynthetic gene clusters discovered

The researchers led by Yi-Ming Shi and Helge Bode identified 1,000 biosynthetic gene clusters, over half of which are previously unknown. Using homologous expression and chemical structure analysis the research team uncovered a veritable biochemical treasure trove. But what does the nematode host benefit from these bacterial substances?

"Our bioactivity evaluation demonstrates that the prevalent compounds are eukaryotic proteasome inhibitors that presumably suppress the immune system of insects, but we identified also other against insects or suppressors of the insect immune system. Thus our findings account for the molecular functional basis of these bacterial natural products," says Yi-Ming Shi, first and correspondence author of the publication. "Among the , many natural products stand out not only due to their unusual chemical structural features and modes of action, but also their prevalence across different bacteria taxa. This implies possible universal chemical weapons in bacteria."

Identification and functional characterization, which were performed in cooperation with Yonggyun Kim from Andong National University (Korea), Michael Groll from Technical University of Munich, and Rolf Müller from Helmholtz Institute for Pharmaceutical Research Saarland, revealed how bacteria orchestrate the interplay of natural products to maintain their symbiotic lifestyles, while pointing to the enormous capabilities of the genus Xenorhabdus in particular to produce novel natural products for drug leads. As such, however, this work also lays important groundwork for significantly accelerating the discovery and refinement of natural products in microbiomes from other niches.

The study is published in Nature Chemistry.

More information: Yi-Ming Shi et al, Global analysis of biosynthetic gene clusters reveals conserved and unique natural products in entomopathogenic nematode-symbiotic bacteria, Nature Chemistry (2022). DOI: 10.1038/s41557-022-00923-2

Journal information: Nature Chemistry

Provided by Max Planck Society

Citation: Genomic studies open up a wealth of bioactive small molecules in insect-killing bacteria (2022, May 2) retrieved 1 October 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Drugs from nature—big effects of multiple compounds in small amounts


Feedback to editors